BioPharma Dive2d
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...
AstraZeneca Pharma share price rises 3% on CDSCO nod for Eculizumab
AstraZeneca share rose after it that the company has secured permission to import pharmaceutical formulations of new drug for ...
Indian drugmakers likely to gain under the new US government
Industry experts are hopeful of India's trajectory as the US is facing shortages and backorders. They said with many ...
AstraZeneca gains on getting nod from CDSCO to import new drug Eculizumab
AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...
United States Oral Solid Dosage Contract Manufacturing Market Set to Reach $11.70 Billion by 2029
The "United States Oral Solid Dosage Contract Manufacturing Market, By Region, Competition, Forecast & Opportunities, ...
Medindia12d
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
VK2375 is being developed in both oral and subcutaneous formulations for the potential ... has been approved by the U.S. Food and Drug Administration and is currently marketed in various dosage ...
GlobalData on MSN6d
Eisai and Biogen’s subcutaneous Leqembi set for FDA review
Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment ...
Reuters on MSN12d
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo (Dec. 27)
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Softgel Capsule Market Size To Hit USD 2.07 Billion By 2032, Growing At A CAGR Of 6.17% – SNS Insider
According to SNS Insider, The Softgel Capsule Market size was valued at USD 1.21 billion in 2023 and is expected to reach USD 2.07 billion by 2032, growing at a CAGR of 6.17% over the forecast period ...
Stocks to Watch Today
Stocks like Hatsun Agro Products, Metro Brands, Bharat Petroleum Corporation, Mastek, One Mobikwik Systems, Jammu & Kashmir Bank, Satin Creditcare Network, IRCTC, Power Finance Corporation, Suraksha ...